Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
CATrends: Empty Space in Consumer Goods
Lawsuits aren’t giving any slack when it comes to underfilled packages.
Domino’s $6.99 Pizzas
Why advertise a price that no consumer will pay?
Columbia. Engineered For Whatever.
Columbia is made for anything nature could throw at you.
Military Glasses & Libiyi
Watch out for online retailers’ bait-and-switch tactics.
America’s Best
Why your options may be limited in claiming this eyeglasses deal.